Status: Not yet recruiting
Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension
This is a phase III, non-inferiority, randomized, double-blind, double-dummy, active-controlled, multicenter study to compare the efficacy and safety of N0877 versus double combination with already established efficacy on systolic blood pressure (SBP) in the sitting position in the medical office in patients with SAH after 8 weeks of treatment.
Participants needed: 292
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Eurofarma Laboratorios S.A.Updated: Nov 27, 2024Locations: 1
Eligibility criteria
Ability to confirm voluntary participation and agree to all purposes of the stud... [+4]
Pregnant or lactating women. [+10]